Rival Companies to Work Together in COVID Fight
Pharmceutical giant Merck & Co. will help produce rival Johnson & Johnson’s newly approved coronavirus vaccine in an effort to expand supply more quickly, the White House announcedTuesday.
The partnership will help advance the administration’s goal of speeding up production of the single-dose vaccine and accelerate the nation’s plans to vaccinate nearly all adult Americans in the coming months.
The government will facilitate this partnership in several key ways, including invoking the Defense Production Act to equip two Merck facilities to the standards necessary to safely manufacture the vaccine, and asking the Department of Defense to provide daily logistical support to strengthen Johnson & Johnson’s efforts.
White House press secretary Jen Psaki also announced Tuesday that the federal government was increasing supply of the Moderna and Pfizer vaccines to states next week to 15.2 million doses per week, up from 14.5 million previously. In addition, states will receive 2.8 million doses of the newly approved Johnson & Johnson vaccine, Psaki said.
“So they are receiving a total of 18 million doses,” said Psaki.
All those developments enabled President Biden to announce Tuesday afternoon that the United States will have enough vaccine supply to vaccinate all American adults for coronavirus by the end of May, crediting a “stepped up process” under his administration.
“We’re now on track to have enough vaccine supply for every adult in America by the end of May,” Biden said in remarks at the White House. “When we came into office the prior administration had contracted for not nearly enough vaccine to cover adults in America. We rectified that.”
In addition, the AP reports that on n a call with governors Tuesday, White House coronavirus coordinator Jeff Zients said states should prepare for administering 16-17 million total weekly doses of Pfizer and Moderna vaccines by the end of March, climbing to 17-18 million weekly by early April.
The supply of J&J doses to states is expected to climb to 4-6 million weekly doses by the end of March and 5-6 million doses weekly through the end of April.
More than 800,000 doses of the J&J vaccine will also be distributed this week to pharmacies to administer in a separate federally-run program that also includes 2.4 million doses of the other two shots. Both figures are expected to steadily increase, as the White House increasingly looks to the capacity of pharmacy chains like CVS and Walgreens to help speed the nation’s mass vaccination campaign.
In The News
Health
Voting
Health
WASHINGTON (AP) — The U.S. is recommending a "pause" in administration of the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots.In a joint statement Tuesday, the Centers for Disease Control and Prevention and the Food and Drug Administration said they... Read More
A new study, led by University of Utah Health scientists, suggests that more than half of doctors, nurses, and emergency responders involved in COVID-19 care could be at risk for one or more mental health problems, including acute traumatic stress, depression, anxiety, problematic alcohol use, and... Read More
BETHESDA, Md. - The National Institutes of Health released a call for research on how COVID-19 may be indirectly and directly impacting those with HIV. According to the written statement the, “COVID-19 pandemic is affecting people with or at risk for HIV by interfering with HIV... Read More
The Bureau of Justice Statistics issued a report stating those with intellectual disabilities are sexually assaulted at a rate seven times higher than those without disabilities. “Persons with developmental disabilities are at highest risk of sexual assault in this country,” said Nora Baladerian, the founder and... Read More
In a sign that the recovery from the coronavirus pandemic is continuing, the Washington D.C. area’s largest hotel -- the Gaylord National Resort at National Harbor -- will reopen July 1. Hotel owner Ryman Hospitality Properties lost more than a year of convention and conference business... Read More
When James Reidy worked at the Labor Department in the 1980s, processing worker compensation claims from asbestos exposure in shipyards, he found that many of the cases stalled over the question of causation. The workers had been exposed to asbestos in their work, some for decades,... Read More
